Dr. Scott Boyer joins Chemotargets as new CEO

by GENESIS Biomed

With the new incorporation, the company consolidates its transition from a software business to an AI-driven biotech

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Described two new variants of the TLR7 g...

by Hospital Universitari de Bellvitge

Older age, being a male, or suffering from certain chronic diseases su...

Photos Stream